Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market
Go back to Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.19 -0.25 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.44 | 52 Week High | $42.49 | |||
| Open | $20.44 | 52 Week Low | $16.64 | |||
| Day High | $20.57 | P/E | N/A | |||
| Day Low | $20.10 | EPS | $-0.42 | |||
| Volume | 1,409,869 | |||||
| Anavex Life Sciences Corp. (NASDAQ: AVXL) | Delayed: 1.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.36 | 52 Week High | $8.30 | |||
| Open | $1.40 | 52 Week Low | $2.43 | |||
| Day High | $1.40 | P/E | N/A | |||
| Day Low | $1.31 | EPS | $-0.22 | |||
| Volume | 1,055,181 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 149.88 +1.58 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.30 | 52 Week High | $65.46 | |||
| Open | $147.11 | 52 Week Low | $47.97 | |||
| Day High | $150.00 | P/E | 101.96 | |||
| Day Low | $147.11 | EPS | $1.47 | |||
| Volume | 9,007,883 | |||||
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 141.31 -0.69 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.00 | 52 Week High | $58.46 | |||
| Open | $141.38 | 52 Week Low | $31.25 | |||
| Day High | $142.77 | P/E | N/A | |||
| Day Low | $140.84 | EPS | $-0.69 | |||
| Volume | 815,508 | |||||
| (NASDAQ: NTHI) | Delayed: 2.90 +0.13 (4.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.77 | 52 Week High | $ | |||
| Open | $2.80 | 52 Week Low | $ | |||
| Day High | $2.96 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $ | |||
| Volume | 106,237 | |||||



